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Abstract. The aim was to determine the precision of a noninvasive near-infrared spectroscopy (NIRS)-based
tissue oximeter (OxyPrem v1.3). Using a linear mixed-effects model, we quantified the variability for cerebral
tissue oxygenation (StO2) measurements in 35 preterm neonates to be 2.64%, a value that meets the often-
articulated clinicians’ demand for a precise tissue oxygenation measurement. We showed that the variability of
StO2 values measured was dominated by spontaneous systemic hemodynamic fluctuations during the meas-
urement, meaning that precision of the instrument was actually even better. Based on simultaneous and con-
tinuous measurements of peripheral arterial oxygenation and cerebral StO2 with a second sensor, we were able
to determine and quantify the physiological instability precisely. We presented different methods and analyses
aiming at reducing this systematic physiological error of in vivo precision assessments. Using these methods,
we estimated the precision of the OxyPrem tissue oximeter to be ≤ 1.85%. With our study, we deliver relevant
information to establish highly precise cerebral oxygenation measurements with NIRS-based oximetry, facilitat-
ing the further development toward a substantially improved diagnosis and treatment of patients with respect to
brain oxygenation. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of
this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.23.6.067003]
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1 Introduction
Infants born preterm are vulnerable to hypoxic and ischemic cer-
ebral insults that can lead to long-term morbidity.1 Diagnostic
methods to early detect these conditions and to prevent lesions
are urgently needed. Optical methods such as near-infrared
spectroscopy (NIRS) have the potential to fulfill this need by
assessing cerebral oxygenation and blood perfusion (hemo-
dynamics) noninvasively, especially by being able to measure
the tissue oxygenation (StO2) as an absolute parameter.
2,3 The
measurement of cerebral StO2 may be useful for detecting
situations where the oxygenation of the brain is impaired; the
hope is that by properly adjusting the cerebral oxygenation,
brain lesions will be prevented. However, the in vivo precision
of NIRS-based oximetry has repeatedly been reported to be
insufficient for clinical practice.2,3
In previous studies, the reproducibility of StO2 was
examined for various NIRS-based oximeters. For example,
Sorensen and Greisen4 reported a precision of 5.2% for the
NIRO 300 (Hamamatsu Photonics, Hamamatsu, Japan).
Recent studies showed that a higher precision in neonates of
2.0% (term) to 4.2% (preterm) can be achieved by excluding
inhomogeneous tissue for the OxiplexTS (ISS, Champaign,
Illinois).5
Technically, precision is quantified by the variation of
repeated measurements with an instrument at an unchanged
specimen, i.e., the true value of StO2 is assumed to be constant.
In studies in vivo, this is not necessarily given as numerous
regulation processes may cause physiological changes and thus
changes in true StO2. These physiological changes contribute
to the observed variability, causing it to be higher than the
variation caused by the device (i.e., the precision). However,
vital parameters associated with changes in true StO2, such as
heart rate or arterial oxygen saturation (SaO2), were unfortu-
nately not monitored during the measurements in previous stud-
ies, such as Refs. 5 and 6. Especially, SaO2 variability matters
because it acts as an “input parameter,” and changes in SaO2 are
directly reflected in StO2.
6
Data on the influence of these physiological changes or
spontaneous systemic hemodynamic fluctuations on precision
of NIRS measurements are sparse and inconclusive. While
Hyttel-Sorensen et al.7 found that on the adult forearm most
of the variation was not due to spontaneous ﬂuctuations, Menke
et al.8 stated that “most of the variation between repeated rSO2
measurements is due to physiological variation” in their mea-
surements on the forehead of preterm and term neonates.
The aim of our study was first, to determine the precision of
the OxyPrem NIRS-based oximeter device in preterm neonates
and second, to assess physiological changes during such mea-
surements. Furthermore, we aimed to present several approaches
reducing the impact of spontaneous systemic hemodynamic
fluctuations on the measurements.
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2 Methods
2.1 Subjects
The study was performed at the Department of Neonatology,
University Hospital Zurich. The study protocol was accepted
by the ethical committee of Zurich (KEK 2010-0102/2) and
received regulatory approval from Swissmedic (2010-MD-
0019). Parental consent was obtained in all cases prior to
enrollment.
Thirty-seven clinically stable preterm infants breathing spon-
taneously on room air were enrolled in our study. The demo-
graphic data of the evaluated infants are shown in Table 1.
Infants with congenital malformations were excluded.
2.2 Instrumentation
StO2 was measured with our in-house built NIRS-based oxi-
meter OxyPrem v1.3, peripheral arterial oxygen hemoglobin
saturation (SpO2) was acquired by a Sensmart Model X-100
Universal Oximetry System with “6100CN cloth sensor—neo-
natal” pulse oximetry sensor (Nonin Medical, Inc., Plymouth,
Minnesota).
The OxyPrem v1.3 sensor consists of four continuous-wave
light sources and two light detectors [Fig. 1(c)], linearly and
symmetrically arranged with sources placed in between the
detectors. Each source is equipped with multiple LEDs (690,
760, 805, and 830 nm). The two detectors D1, D2, and sources
S1, S4 form an outer region of interest (ROI1) with source–
detector separations (SDS) of 15 and 35 mm, respectively.
Both detectors and sources 2 and 3 form an inner region
(ROI2) with SDS of 20 and 30 mm, respectively. Except for
this difference in source positions and SDS, both ROIs are tech-
nically identical and the major difference is that slightly different
tissues are probed with ROI1 offering deeper tissue sensitivity
(due to the longer SDS). Sources and detectors are embedded in
flexible silicone, and the sensor’s shape is adapted for easy
application to strongly curved surfaces such as the tiny head of
neonates.
The multidistance algorithm is based on the following steps:
the ambient light intensity is subtracted. From the slope of
intensity decrease over distance, the effective attenuation is
calculated which is then transformed into concentrations of oxy-
hemoglobin and deoxyhemoglobin. Finally, StO2 is calculated
as the ratio of oxyhemoglobin over the sum of oxyhemoglobin
and deoxyhemoglobin. For each ROI, StO2 is calculated
individually. The mean of both StO2 values for ROI1þ2 StO2 is
calculated as well.
We employ a self-calibrating algorithm,9 which exploits
the sensor’s symmetry to cancel most influential factors. For
instance, differences in light coupling between sources of
detectors are automatically canceled to a high degree. Mainly,
this algorithm enables OxyPrem to compensate for local inho-
mogeneities such as an unequal distribution of hair underneath
the sensor, birth marks, hematoma, smears of blood, or meco-
nium under a source or detector. This algorithm also increases
robustness to motion artifacts.10 OxyPrem thus provides a robust
StO2 measurement.
In addition, in contrast to many other oximeters, OxyPrem’s
StO2 is insensitive to the total hemoglobin concentration.
11
Although designed for cerebral oximetry in neonates, it has
a similar capability to assess the oxygenation in deeper layers
of tissue as common adult sensors12 and is therefore a tool
that determines StO2 in a variety of patients and anatomical
locations.
2.3 Data Acquisition
Five 1-min measurements were conducted with an OxyPrem
sensor placed over the left frontotemporal lobe (FTL) on the
head of a preterm neonate. In between, the sensor was removed
and reattached (resited) at approximately the same location
without marking. The FTL was selected because it is a common
region to place NIRS sensors as it is not covered by hair. Before
Table 1 Demographic data of preterm infants (n ¼ 35).
Median Range
Gestational age (weeks) 33(2/7) 25(1/7) to 36(1/7)
Postmenstrual age (weeks) 35(5/7) 32(1/7) to 38(5/7)
Birth weight (g) 1630 730 to 2820
Weight at measurement (g) 2070 1460 to 3000
(a) (b) (c)
Fig. 1 Visualization of the OxyPrem sensor placements (a) FTL, (b) OL and the sensor design in bottom
view: (c) light detectors (D) in green and light sources (S) in red (ROI1)/orange (ROI2). From right to left:
D1, S1, S2, S3, S4, and D2. ROI1 is constituted by D1, D2, S1, and S4. ROI2 is constituted by D1, D2, S2,
and S3. The neonatal head model is based on a fMRI scan of a 35-week-old infant.
Journal of Biomedical Optics 067003-2 June 2018 • Vol. 23(6)
Kleiser et al.: In vivo precision assessment of a near-infrared spectroscopy-based. . .
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 1/31/2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
the start of the next measurement, we waited for sensor LEDs to
regulate (see Fig. 2 for a typical example).
To assess the spontaneous systemic hemodynamic ﬂuctua-
tions, we recorded SpO2 on the right arm and placed a second
OxyPrem sensor over the occipital lobe (OL) with the center of
the sensor being positioned 1 cm above the inion. The OL was
selected as a reference location because it is far away from
the FTL and thus avoids cross talk between the two sensors.
To obtain data with high signal-to-noise ratio, we recruited pref-
erably light-haired subjects. The placement of the OxyPrem sen-
sors over the head of a neonate is shown in Figs. 1(a) and 1(b).
2.4 Data Analysis
The StO2 and SpO2 signals were synchronized by setting an
event mark recorded directly after having started the recording.
Data selection and analysis were performed as follows:
I. Typically five median values (one for each 1-min
measurement, called “block median”) per subject
were analyzed by a linear mixed-effects model with
subject as factor (LMEM13,14) using the statistics soft-
ware R (Version 3.3.2).15 The average residual corre-
sponds to the variability within subjects and is
therefore called intrasubject standard deviation
(SDintraSubj). This approach has been used in previous
studies, for instance, in Ref. 16. We evaluated StO2 of
ROI1 and ROI2 individually as well as their average
StO2 (ROI1þ2) and included all data, irrespective of
artifacts caused by drops in SpO2 or subject movement
(“all available”).
II. Visual inspection of the StO2 data revealed several
subjects in which ≥ 3 out of 5 blocks were containing
artifacts, mostly motion artifacts or desaturations.
These subjects were excluded for further analysis
with the LMEM (“manual rating”). This approach was
inspired by functional studies, where artifacts are often
rated manually.
III. In another analysis with an LMEM, subjects showing
high physiological variation between block medians
were removed. The criterion for subject removal was
an SD between the five block medians of > 2% for
SpO2 (“stable SpO2”). SpO2 reflects systemic physi-
ology and hence thresholds for variability in SpO2
lead to a dataset with smaller physiological changes,
but also less data for analysis. Our thresholds were
selected as a trade-off between removing physiologi-
cally unstable subjects and retaining data. We set a
strict SpO2 threshold because changes in SpO2 lead
to concurrent changes in StO2 anywhere in the body.
7
IV. In this dataset, an additional criterion for stable OL StO2
was added (SD < 7.5%), to exclude drifts in cerebral
StO2 which are possible even if SpO2 is stable. The
threshold was set to remove only the most severe cases,
i.e., it removed only one, severely affected subject.
V. and VI. Two additional analyses were performed,
requiring variability of StO2 within a block to be
below a threshold. Variability during the blocks was
determined by taking the median absolute deviation
(MAD17) of all samples within a block. We chose
MAD as a measure because it is more robust against
outliers than the SD. For better comparability, a factor
of 1.4826 was applied (scaled MAD18) to obtain
similar values to SD for artifact free, normally distrib-
uted data. We then compared scaled MAD to two
different thresholds: < 2.5% (“var < 2.5%”) and < 1%
(“var < 1%”), and analyzed these two datasets with
the LMEM. We chose two different thresholds for
within-block variability. 2.5% was chosen to filter
the most varying blocks only and 1% was chosen to
ensure negligible variation during the blocks.
(a)
(b)
Fig. 2 Typical time series of one patient (ID 12) showing themultiply removed and reattached (resited) FTL
and fixed OL StO2 and SpO2 signals. The gray backgrounds indicate the 1-min measurement periods.
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Ratios between variability during the blocks for ROIs give
insight into the amount of physiological changes present in
the StO2. Calculation starts with scaled MAD of all samples
of a block. Then, the scaled MAD of one ROI is divided by
that of the other, and in the next step the mean of the five blocks
is calculated. The mean and median over all subjects are shown
in Table 3. As this analysis only takes variability within one
block into account, i.e., without sensor resiting, these ratios
are not affected by this procedure and we would not expect
higher variability in FTL StO2 compared with OL StO2. Short-
term artifacts have marginal influence on MAD within a block
of one minute. We, therefore, associate the numbers in Table 3
with the level of physiological changes contained in the StO2 of
the different ROIs.
3 Results
In total, 37 patients were included in this study. Data from two
subjects were discarded due to a complete data loss. From
the remaining 35 patients, all available data were analyzed.
In some of these subjects, it was not possible to obtain suffi-
ciently reliable data and datasets are partially incomplete:
only four measurements were performed (ID 19); due to
technical problems with the pulse oximeter instrument, SpO2
recordings are not available (IDs 3 and 18); OL StO2 data
were only available in a single complete measurement and there-
fore disregarded (ID7).
A typical time series of one patient (ID 12) of the FTL and
OL StO2 (ROI1þ2) and of SpO2 is shown in Fig. 2, which shows
that all signals are strongly affected by spontaneous fluctuations.
Block medians of SpO2 that indicate the degree of systemic
physiological changes are shown in Fig. 3(a). The SD of SpO2
throughout the whole recording varies considerably between
subjects and is shown in Fig. 3(b). In a number of subjects,
there are high values meaning significant variation over time
and only in very few cases SD is <1%.
The block medians of StO2 are graphically presented as box
plots in Fig. 4. These show StO2 for ROI1, ROI2, and ROI1þ2 of
FTL and OL sensors, respectively. In all ﬁgures, a number of
subjects with a high variability of values were found, whereas
for many subjects there is very little variation.
This finding is illustrated even better when plotting the vari-
ability of block medians of StO2: SD and scaled MAD for
the block medians of StO2 of each subject are shown in
Fig. 5. Data are sorted in ascending order and the median val-
ues of both are indicated by horizontal lines. SD-sorted
1.4826 ×MAD allows for subject-wise comparison of SD
and scaled MAD.
The resulting SDintraSubj for StO2 and SpO2 obtained by
different analyses (I to VI) are shown in Table 2. A number of
subjects (subj) and number of blocks considered for each
analysis type are provided. Different numbers of subjects with
available data or blocks filtered out by the applied criteria are
the causes for given spans. For example, “all available” contains
FTL data from 35, OL data from 34, and SpO2 data from 33
subjects, resulting in a span of 33 to 35, respectively.
An analysis of the mean of variability during the 1-min
measurements for StO2 is shown in Table 3.
4 Discussion
Taking all available data of our precision assessment in clini-
cally stable preterm infants into account results in a variability
of 2.64% for OxyPrem. However, we attribute a major stake
of this number to physiological changes occurring during the
measurement. Different methods for reducing the influence of
physiological changes suggest that OxyPrem precision is
actually superior and ≤ 1.85%.
What does precision in cerebral monitoring with NIRS-based
oximeters mean for clinical applications? Precision corresponds
to the reliability of the numbers displayed to the clinician and is
device specific. If an instrument displays an StO2 of 60% and we
assume that the error of measurement is normally distributed
around the 60%, we would like to know the probability that
the true StO2 is in reality < 55%, values that are considered to
be too low.19 For an instrument with 5% precision, in 1 out of
6 cases the true StO2 is indeed < 55%, whereas for 2.5%
precision it is only 1 out of 46 and for 2% precision 1 out of
172 cases, respectively. Thus, precision is directly linked to
how trustworthy a displayed StO2 is and it represents a crucial
parameter when clinically applying cerebral oximetry.
(a) (b)
Fig. 3 (a) Box plot visualizing the variability between the five block medians of SpO2. Subjects with
unstable SpO2 are painted in red. (b) SD of SpO2 throughout the whole recording for all subjects.
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(a) (b)
(c) (d)
(e) (f)
Fig. 4 Box plots visualizing the variability between the five block medians. Left (a, c, e): StO2 of the FTL
sensor that was repeatedly removed and reattached (resited). Right (b, d, and f): StO2 of the fixed OL
sensor. (a and b) Results of ROI1, (c and d) of ROI2, and (e and f) of ROI1þ2. Manual artifact rating
indicated multiple artifacts in five subjects (IDs 15, 16, 17, 18, and 22). Colored data correspond to
subjects not having passed the quality criteria for stable physiology due to: missing SpO2 data (blue),
unstable SpO2 (red) or unstable OL StO2 (brown). The lower subplots indicate how many out of
the typically five blocks per subject exceeded the threshold (T) for variation during these periods
(light green: “var > 2.5%”, dark green: “var > 1%”).
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(a) (b)
(c) (d)
(e) (f)
Fig. 5 StO2 variability expressed as SD and scaled median absolute deviation (scaled MAD) of the block
medians. Data are sorted by ascending SD and scaled MAD. Additionally scaled MAD is displayed with
ordering by ascending SD for a subject-wise comparison. Median values of both SD and scaled MAD are
indicated by horizontal lines. Left (a, c, and e): StO2 of the FTL sensor, which was repeatedly removed
and reattached (resited). Right (b, d, and f): StO2 of the fixed OL sensor. (a and b) show results of ROI1,
(c and d) show results of ROI2, and (e and f) show results of ROI1þ2.
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To determine the precision in vivo, a sensor is repeatedly
placed over the same tissue and the variation of the values
between these resitings corresponds to the precision. This is
only true, if the measured physiological parameter changes
negligibly. Under this assumption, the results show that our
new in-house developed NIRS-based oximeter device OxyPrem
with a precision of 2.64% achieves the requirements for clinical
practice, which are requested to be <3% for cerebral oxygena-
tion of preterm infants.2,3
Typically this precision corresponds to 5% for other instru-
ments: e.g., 5.2% for neonates4 and 6.1% were reported for
anesthetized children20 for the NIRO-300 (Hamamatsu), 6.7%
in neonates21 and 7.1% in anesthetized children20 for the
INVOS 5100C adult SomaSensor (Medtronic), and 4.8% in
term born neonates for the INVOS 5100C OxyAlert neonatal
sensor.22 A better repeatability in neonates with SDintraSubj of
1.7% was reported8 for a discontinued device7 and 2.8%
for the FORE-SIGHT neonatal small dual sensor (Casmed),22
However, for both sensors a decreased dynamic range of
changes in StO2 was reported,
22,23 i.e., a lower sensitivity.
SDintraSubj of 2.76% in 30 mostly preterm infants was demon-
strated for a prototype NIRS device employing a self-calibrating
algorithm.16 By excluding tissue homogeneity, a higher preci-
sion of 2.0% in term infants and 4.2% in preterm infants was
determined for the OxiplexTS (ISS).5
OxyPrem is capable of measuring two independent StO2
values (ROI1 and ROI2). We expected that the average of these
two StO2 (ROI1þ2) would perform better than each individual
ROI, which is not the case. The reason is that ROI1 incorporates
the longest source–detector distance available (35 mm), which
obviously adds stability. We consequently refer to ROI1 when
we speak of the precision of OxyPrem.
Precision is only correctly determined if the true StO2 does
not change between measurements. However, this assumption is
incorrect because the human body constantly regulates and
creates physiological changes. So far, these fluctuations were
deemed negligible. It is one major result of this study to be the
first to quantify these fluctuations and to estimate the respective
errors in the precision calculation. Indeed, it was shown that
these fluctuations are often not negligible at all. Therefore, an
assessment of precision of an instrument requires a correction
for this influence.
4.1 Contribution of Spontaneous Physiological
Changes
In subject 12, SpO2 ﬂuctuates with an SD of almost 4% (Fig. 3).
Figure 2 shows that in SpO2 and both StO2 signals of subject 12,
there are significant oscillations present which is due to coupling
between SpO2 and StO2.
7 In addition, most of the variation in
the FTL StO2 is not actually caused by the sensor resiting.
Furthermore, in the OL StO2 even stronger changes are visible,
although the sensor was kept in place (Fig. 2).
There are different types of contributions to the variability
observed in this study. The first type is variations occurring
when the true StO2 is unchanged. This type is defined as the
precision of a device, i.e., (1) random noise, (2) changes in
shape of the sensor, and (3) differences in optical coupling
due to the resiting of the sensor. In an in vivo assessment, how-
ever, changes in the true StO2 are present. Some are caused by
the sensor resiting: (4) tissue heterogeneity, if the measurement
location is not kept exactly the same, (5) changes in skin
perfusion and oxygenation caused by the manipulation, and
(6) changes in brain perfusion and in arterial and venous
compartment sizes because the head was moved during the
manipulation. In addition, spontaneous physiological changes
may affect cerebral NIRS measurements.24–27 These occur inde-
pendently of the sensor’s removal and reattachment process
and reflect true alterations in StO2: (7) systemic changes in
SpO2 (desaturations and fluctuations and/or oscillations) and
(8) changes in blood flow, hemoglobin concentration, and
oxygen consumption of the brain due to different regulation
processes.
The definition of precision is the random error associated
with measuring an unchanged quantity repeatedly. However,
most of the contributions to the variability listed above corre-
spond to changes of the true StO2 (contributions 4 to 8).
In the analysis I including all subjects (“all available”)
Table 2 Variability (Var) between the 1-min measurements (blocks) of SpO2 and StO2 of the FTL and OL. Variability expressed as within-subject
(SDintraSubj) in StO2 [%] calculated by LMEM based on all data and after applying different criteria (I–IV). For each analysis, the minimal andmaximal
number of available subjects and blocks passing the quality criteria is given, e.g., II “manual rating” contains FTL data from 30, OL data from 29, and
SpO2 data from 29 subjects, i.e., a span of 29 to 30.
Method Subjects (n) Blocks (n)
ROI1 FTL
[%]
ROI2 FTL
[%]
ROI1þ2 FTL
[%]
ROI1 OL
[%]
ROI2 OL
[%]
ROI1þ2 OL
[%]
SpO2
[%]
I All available 33 to 35 164 to 174 2.64 8.21 4.84 3.06 5.79 4.15 2.35
II Manual rating 29 to 30 144 to 149 2.02 4.14 2.77 2.76 5.10 3.61 1.44
III Stable SpO2 25 124 1.94 4.18 2.76 2.24 5.13 3.54 1.03
IV Stable physiology 24 119 1.85 3.82 2.54 2.08 3.53 2.65 1.01
V Var < 2.5% 30 to 35 120 to 155 2.11 3.93 2.77 2.32 2.86 2.62 -
VI Var < 1% 20 to 27 54 to 88 2.04 2.65 2.56 1.77 2.70 2.21 -
Table 3 Ratios of variability during the 1-min measurements.
ROI1
OL/FTL
ROI2
OL/FTL
ROI1þ2
OL/FTL
ROI1∕ROI2
FTL
ROI1∕ROI2
OL
Median 1.07 1.18 1.20 0.74 0.79
Mean 1.34 1.57 1.42 0.78 0.77
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(Table 2), SDintraSubj for ROI1 OL StO2, SpO2, and ROI1 FTL
StO2 are almost the same. This shows that the major contribu-
tion to variability cannot be the resiting process and that
SDintraSubj corresponding to the observed variability is system-
atically higher than the instrument-related variability in repeated
measurements (i.e., precision, contributions 1 to 3).
Figure 2 shows another effect that matters for in vivo
precision experiments. The shorter the measurement periods,
the stronger is the effect of physiological ﬂuctuations. In this
subject (ID 12), one period of physiological ﬂuctuation is ∼15 s.
Due to 1-min averaging, these changes cancel to a certain
degree. Therefore, although SD of SpO2 is ∼4% (Fig. 3), this
measurement passed the criteria for stable physiology (“stable
physiology”) with an SD of 1.1% between the block medians.
With shorter block sizes, this smoothing effect diminishes,
resulting in higher SDintraSubj. This may explain the different
precisions determined by different research groups for the same
sensor on the same patient groups.
In Table 3, the ratio for OL/FTL is >1 in all three cases
(ROI1, ROI2, and ROI1þ2) and for ROI1∕ROI2 is <1 in both
cases (FTL and OL). As MAD is robust to short-time artifacts
(e.g., motion artifacts), we assume that the variation during the
blocks originates from spontaneous physiological fluctuations
in the StO2 (Fig. 2). Generally, physiological variation in StO2
in the OL is higher than in the FTL. In addition, we see less
variation in StO2 of ROI1 than in ROI2. ROI1 with SDS of
15 and 35 mm collects data from deeper layers of the brain
and averages a larger volume of tissue, leading to a more stable
signal.
4.2 How to Reduce the Effect of Spontaneous
Physiological Changes in Case of
NIRS Reproducibility Measurements
For correctly calculating precision, the true StO2 needs to be
unchanged. However, several subjects showed strong physio-
logical changes during the measurement, invalidating this
assumption. This causes a systematic overestimation of the pre-
cision. To minimize this effect, we applied different criteria to
remove individual blocks or subjects and analyzed the remain-
ing data with the LMEM. Table 2 shows the resulting SDintraSub
and the number of subjects and blocks, which have passed the
respective criteria. For clinical application, there is of course no
requirement for StO2 to remain unchanged and a patient with
variable physiology can be reliably monitored with a NIRS
instrument. Such patients probably are among those benefiting
the most from such monitoring.
II. The approach with manual artifact rating depends on
the person performing the rating. This is a difficult task
because not only movement artifacts but also continu-
ous spontaneous physiological changes have to be
considered. We, therefore, do not favor this approach.
III. The approach to include subjects with stable systemic
physiology (“Stable SpO2”) requires additional sen-
sors in place (SpO2). The criterion allows periodic
fluctuations within the blocks but requires the physi-
ology to be stable throughout the whole experiment.
This approach results in smaller SDintraSubj (Table 2).
In at least one subject (ID 8), a substantial slow trend
in StO2 was observed, which clearly violates the
assumption of stable “true” StO2. This infant was
not identified by the SpO2 criterion. This shows that
although both are coupled,7 SpO2 cannot predict
cerebral StO2. Therefore, monitoring systemic physi-
ology alone is not sufficient to guarantee stable
cerebral StO2.
IV. Thus, we added another criterion based on variability
of OL StO2. We consider the remaining subjects
having “stable physiology,” which is reflected in even
lower SDintraSubj (Table 2), than in the previous
approaches. However, precision is probably still con-
siderably overestimated due to a major physiological
contribution because SDintraSubj of StO2 of the FTL
sensor is almost identical to SDintraSubj of the OL sen-
sor which was not resited.
V. and VI. The approach limiting variability within each
block (“var < 2.5%” and “var < 1%”) discards all
blocks with periodic fluctuation irrespective whether
or not they influence the block median. However,
a slow change in oxygenation is not removed and
still causes an overestimation of SDintraSubj. Especially
the strict criterion with variability <1% discards many
blocks, with only approximately three left per subject
on average, which reduces statistical power.
The box plot in Fig. 4 and the sorted variabilities of all sub-
jects in Fig. 5 show that the majority of subjects have relatively
small deviation between the blocks and only few subjects con-
siderably increase the overall SDintraSubj. Generally, SD and
scaled MAD are similar for normally distributed data. Our data-
set is not normally distributed because scaled MAD provides on
average lower values than SD. The reason is that MAD provides
better robustness to outliers, whereas SDintraSubj is only valid
for normally distributed data. This is further demonstrated by
median values of scaled MAD in Fig. 5 being typically lower
than the SDintraSubj of LMEM (Table 2). Therefore, even in
datasets with strong physiological variability excluded, LMEM
systematically overestimates the variability. This also means
that the precision of OxyPrem is better than 1.85% in reality.
Although the resulting variability still depends on physiological
changes and is still higher than the true precision of the instru-
ment, it definitely is closer to the true precision.
For all discussed methods to obtain the true precision,
SDintraSubj of the repositioned sensor was substantially lower
than in the analysis based on all available data. This indicates
that physiological changes contributed a major part to SDintraSubj.
Neglecting these physiological changes leads to a substantial
overestimation of the precision. The proposed methods lead
to a much reduced and more correct precision, which is still
somewhat overestimated. For future precision studies, we
recommend employing the method requiring stable SpO2 with
some additional criteria to detect trends in StO2, as both sys-
temic and cerebral physiology are required to be monitored
and restricted to certain limits, to reduce their influence on
the precision determination. We thus refer to ROI1 results
with approach “stable physiology” (IV) as best estimate for
OxyPrem precision.
4.3 Strengths and Limitations of this Study
A strength of this study is that we clearly demonstrated how
systemic physiological changes have an impact on precision
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assessments of cerebral oximeters in clinically stable preterm
infants. We further presented several approaches to cope with
this undesired effect; all of them estimate precision more real-
istically than approaches neglecting the effect of physiological
changes. A limitation of this study is that we acquired data only
in preterm infants. We, therefore, cannot conclude a dominant
influence of physiological changes in other patient groups,
although it is very likely that this factor plays also a significant
part for reproducibility studies based on other populations.
We measured SpO2 with a clinical pulse oximeter for the
approaches applying thresholds on SpO2 variability (III and
IV). We consider this pulse oximeter to be reliable in particular
as we only considered changes in SpO2 and since the sensor was
not resited. Therefore, random errors due to sensor placement or
a device-specific SpO2 bias do not affect the exclusion of
subjects.
Do FTL and OL StO2 represent cerebral signals? Influence of
extracerebral tissues has been reported for cerebral measure-
ments in adults28,29 and could potentially also affect our
study. However, the neonatal skull and other extracerebral layers
are thin30 and are therefore less relevant. Furthermore, OxyPrem
employs a multidistance algorithm that effectively cancels
influence of superficial tissue. Therefore, we can safely state
that OxyPrem StO2 reflects cerebral oxygenation in neonates.
OxyPrem has similar deep-tissue sensitivity as common adult
oximeters.12
5 Conclusions
We presented a methodology to assess precision of NIRS-based
oximetry devices. For the first time, we showed that indeed in
neonates, systemic physiology and cerebral regulation cause
major changes in StO2 that invalidate conventional precision
estimates. Therefore, in addition to StO2 of the sensor which
was removed and reattached, SpO2 and StO2 need to be mea-
sured continuously to identify such variations. It is necessary to
correct for this type of variability. Several such methods were
presented. For future studies, we recommend using an analysis
that limits influence of systemic and cerebral physiology to
obtain a proper precision estimate. OxyPrem has shown to be
a highly precise instrument with a precision ≤ 1.85%, which is
better than instrumentation currently used in clinics.
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